During the past decade, Maryhaven conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maryhaven" #1 sponsor was "University of Cincinnati" with 5 trials, followed by "NYU Langone Health" with 2 trials sponsored, "University of California, Los Angeles" with 2 trials sponsored, "New York State Psychiatric Institute" with 1 trials sponsored and "Theresa Winhusen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maryhaven" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 9 trials as a collaborator, "Maryhaven" with 2 trials as a collaborator, "The Emmes Company, LLC" with 2 trials as a collaborator, "Ortho-McNeil Janssen Scientific Affairs, LLC" with 1 trials as a collaborator and "University of Arkansas" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Maryhaven" are "Cocaine Dependence" (4 trials), "Heroin Dependence" (2 trials), "Opioid Use Disorder" (2 trials), "ADHD" (1 trials) and "Drug Abuse" (1 trials). Many other conditions were trialed in "Maryhaven" in a lesser frequency.

Most popular intervention types in "Maryhaven" are "Drug" (6 trials), "Behavioral" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Behavior Therapy" (1 trials), "Buprenorphine + Naltrexone" (1 trials), "Buprenorphine-Naloxone" (1 trials) and "Buprenorphine/naloxone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maryhaven" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maryhaven". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Maryhaven, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maryhaven, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".